A Randomize, Placebo-controlled, Crossover Study to Measure the Effect of Alosetron on Mucosal Blood Flow in Female Healthy Volunteers and Diarrhea-predominant IBS Subjects

Trial Profile

A Randomize, Placebo-controlled, Crossover Study to Measure the Effect of Alosetron on Mucosal Blood Flow in Female Healthy Volunteers and Diarrhea-predominant IBS Subjects

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 May 2015

At a glance

  • Drugs Alosetron (Primary)
  • Indications Irritable bowel syndrome
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 08 Apr 2009 Actual patient number (49) added as reported by ClinicalTrials.gov.
    • 15 Oct 2008 Actual start date changed from Nov 2006 to Dec 2006 as reported by ClinicalTrials.gov.
    • 04 Apr 2008 Status changed from recruiting to completed, according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top